Palla Pharma Ltd
ASX:PAL
Gross Margin
Palla Pharma Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | AU |
Market Cap | 47.8m AUD |
Gross Margin |
-38%
|
Country | US |
Market Cap | 226.7B USD |
Gross Margin |
40%
|
Country | US |
Market Cap | 197.8B USD |
Gross Margin |
58%
|
Country | US |
Market Cap | 45.3B USD |
Gross Margin |
51%
|
Country | CH |
Market Cap | 37.5B CHF |
Gross Margin |
36%
|
Country | US |
Market Cap | 41.8B USD |
Gross Margin |
35%
|
Country | KR |
Market Cap | 55.4T KRW |
Gross Margin |
49%
|
Country | US |
Market Cap | 32.4B USD |
Gross Margin |
59%
|
Country | IE |
Market Cap | 26.4B USD |
Gross Margin |
30%
|
Country | US |
Market Cap | 25B USD |
Gross Margin |
37%
|
Country | US |
Market Cap | 21B USD |
Gross Margin |
60%
|
Profitability Report
View the profitability report to see the full profitability analysis for Palla Pharma Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Palla Pharma Ltd's most recent financial statements, the company has Gross Margin of -37.7%.